Search Results Search Sort by RelevanceMost Recent Case and Commentary May 2022 Do You Know How to Assess Risks Posed by Over-the-Counter Vitamin A Supplements? Dina H. Zamil, Emily K. Burns, Ariadna Perez-Sanchez, MD, and Rajani Katta, MD Label analysis is key to educating patients about risks of vitamin A-containing supplements. AMA J Ethics. 2022;24(5):E376-381. doi: 10.1001/amajethics.2022.376. Case and Commentary Jun 2022 Should Children Be Enrolled in Clinical Research in Conflict Zones? Dónal O’Mathúna, PhD and Nawaraj Upadhaya, PhD Research that places subjects and investigators at risk of additional harm must be considered carefully. AMA J Ethics. 2022;24(6):E463-471. doi: 10.1001/amajethics.2022.463. Case and Commentary Jun 2022 هل يجب تسجيل الأطفال في الأبحاث السريرية في مناطق الصراع؟ Dónal O’Mathúna, PhD and Nawaraj Upadhaya, PhD AMA J Ethics. 2022;E463-471. doi: 10.1001/amajethics.2022.463. Case and Commentary Mar 2023 How Should Clinicians and Researchers in Government Respond to Threats to Their Offices? Daphne Mlachila, MD, MPH During the COVID-19 pandemic, clinician policy makers have faced unprecedented challenges to their roles in governance. AMA J Ethics. 2023;25(3):E172-178. doi: 10.1001/amajethics.2023.172. Case and Commentary Aug 2005 Hoping for the Best, Preparing for the Worst: Physician to Patient in Clinical Trial Frederic W. Platt, MD Virtual Mentor. 2005;7(8):541-546. doi: 10.1001/virtualmentor.2005.7.8.ccas2-0508. Case and Commentary Nov 2004 Clinical Trials and End-of-Life Decision Making, Commentary 1 David S. Alberts, MD Virtual Mentor. 2004;6(11):477-479. doi: 10.1001/virtualmentor.2004.6.11.ccas1-0411. Case and Commentary Nov 2004 Clinical Trials and End-of-Life Decision Making, Commentary 2 Lucy Godley, MD, PhD Virtual Mentor. 2004;6(11):479-481. doi: 10.1001/virtualmentor.2004.6.11.ccas1-0411. Case and Commentary Nov 2004 Heads or Tails: Randomized Placebo-Controlled Trials, Commentary 1 Charles Weijer, MD, PhD Virtual Mentor. 2004;6(11):482-484. doi: 10.1001/virtualmentor.2004.6.11.ccas2-0411. Case and Commentary Nov 2004 Heads or Tails: Randomized Placebo-Controlled Trials, Commentary 2 Karen Kreiner, MD Virtual Mentor. 2004;6(11):484-485. doi: 10.1001/virtualmentor.2004.6.11.ccas2-0411. Case and Commentary Nov 2004 Who Is That? Expanding the Clinical Encounter Vijaya Arekapudi, MD Virtual Mentor. 2004;6(11):486-487. doi: 10.1001/virtualmentor.2004.6.11.ccas3-0411. Pagination Current page 1 Page 2 Next page Next › Last page Last »
Case and Commentary May 2022 Do You Know How to Assess Risks Posed by Over-the-Counter Vitamin A Supplements? Dina H. Zamil, Emily K. Burns, Ariadna Perez-Sanchez, MD, and Rajani Katta, MD Label analysis is key to educating patients about risks of vitamin A-containing supplements. AMA J Ethics. 2022;24(5):E376-381. doi: 10.1001/amajethics.2022.376.
Case and Commentary Jun 2022 Should Children Be Enrolled in Clinical Research in Conflict Zones? Dónal O’Mathúna, PhD and Nawaraj Upadhaya, PhD Research that places subjects and investigators at risk of additional harm must be considered carefully. AMA J Ethics. 2022;24(6):E463-471. doi: 10.1001/amajethics.2022.463.
Case and Commentary Jun 2022 هل يجب تسجيل الأطفال في الأبحاث السريرية في مناطق الصراع؟ Dónal O’Mathúna, PhD and Nawaraj Upadhaya, PhD AMA J Ethics. 2022;E463-471. doi: 10.1001/amajethics.2022.463.
Case and Commentary Mar 2023 How Should Clinicians and Researchers in Government Respond to Threats to Their Offices? Daphne Mlachila, MD, MPH During the COVID-19 pandemic, clinician policy makers have faced unprecedented challenges to their roles in governance. AMA J Ethics. 2023;25(3):E172-178. doi: 10.1001/amajethics.2023.172.
Case and Commentary Aug 2005 Hoping for the Best, Preparing for the Worst: Physician to Patient in Clinical Trial Frederic W. Platt, MD Virtual Mentor. 2005;7(8):541-546. doi: 10.1001/virtualmentor.2005.7.8.ccas2-0508.
Case and Commentary Nov 2004 Clinical Trials and End-of-Life Decision Making, Commentary 1 David S. Alberts, MD Virtual Mentor. 2004;6(11):477-479. doi: 10.1001/virtualmentor.2004.6.11.ccas1-0411.
Case and Commentary Nov 2004 Clinical Trials and End-of-Life Decision Making, Commentary 2 Lucy Godley, MD, PhD Virtual Mentor. 2004;6(11):479-481. doi: 10.1001/virtualmentor.2004.6.11.ccas1-0411.
Case and Commentary Nov 2004 Heads or Tails: Randomized Placebo-Controlled Trials, Commentary 1 Charles Weijer, MD, PhD Virtual Mentor. 2004;6(11):482-484. doi: 10.1001/virtualmentor.2004.6.11.ccas2-0411.
Case and Commentary Nov 2004 Heads or Tails: Randomized Placebo-Controlled Trials, Commentary 2 Karen Kreiner, MD Virtual Mentor. 2004;6(11):484-485. doi: 10.1001/virtualmentor.2004.6.11.ccas2-0411.
Case and Commentary Nov 2004 Who Is That? Expanding the Clinical Encounter Vijaya Arekapudi, MD Virtual Mentor. 2004;6(11):486-487. doi: 10.1001/virtualmentor.2004.6.11.ccas3-0411.